A Review of the Metabolism and Potential Drug-drug Interactions With Addictive Drugs

J Addict Med. 2022 Jan-Feb;16(1):e30-e39. doi: 10.1097/ADM.0000000000000824.

Abstract

People who use drugs (PWUD) are at increased risk for drug-related harms such as overdose. Additionally, they are also at increased risk of secondary harms from bacterial and other infections such as hepatitis B, hepatitis C, and Human Immunodeficiency Virus. These secondary harms, along with other medical conditions, typically require treatment with prescription medications. When considering treatment options, drug-drug interactions (DDIs) must be considered, unfortunately these interactions are often overlooked with addictive drugs. Although DDIs in PWUD have been reviewed for certain drug classes and specific drugs of abuse, no comprehensive list could be found. The objective of this article is to compile a list of potential DDIs between prescription drugs and addictive drugs to create a list allowing prescribers to make more informed decisions when prescribing a medication to PWUD.

Publication types

  • Review

MeSH terms

  • Drug Interactions
  • HIV Infections*
  • Hepacivirus
  • Hepatitis C*
  • Humans
  • Prescription Drugs*

Substances

  • Prescription Drugs